Home / Ustekinumab / Italy
IT ATC L04AC05 · updated 2 Nov 2026
Ustekinumab shortage in Italy
Is there a Ustekinumab shortage in Italy?
Yes. As of 2 Nov 2026, 3 Ustekinumab products are reported short in Italy, the first since 1 Oct 2025. No return date has been given. Main reason: increased demand.
Also short in Spain, Ireland, Belgium. All countries.
Affected products in Italy
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | PYZCHIVA | SAMSUNG BIOEPIS NL B.V. | 1 Oct 2025 | not given | Increased demand Elevata richiesta |
| IT | PYZCHIVA | SAMSUNG BIOEPIS NL B.V. | 1 Jan 2026 | not given | Increased demand Elevata richiesta |
| IT | IMULDOSA | ACCORD HEALTHCARE, S.L.U. | 3 Jun 2026 | not given | Manufacturing problem Problemi produttivi |
Source
AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.